Format

Send to

Choose Destination
Clin Infect Dis. 2007 Dec 15;45(12):1640-3. doi: 10.1086/523730.

HIV seroprevalence among women opting out of prenatal HIV screening in Alberta, Canada: 2002-2004.

Author information

1
Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, Ottawa, Canada.

Abstract

Alberta, Canada, uses an "opt-out" strategy for prenatal HIV testing. We examined demographic characteristics of and HIV seroprevalence among women opting out. The proportion of total specimens that were from women who opted out decreased from 4.3% in 2002 to 3.6% in 2004 (P<.001), and HIV seroprevalence among these specimens was 0.07%, which was 3.3 times higher than the HIV seroprevalence among specimens from women who opted in. Women opting out may have a higher HIV infection risk.

PMID:
18190327
DOI:
10.1086/523730
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center